Clinical Research Directory

Browse clinical research sites, groups, and studies.

1 clinical study listed.

Healthy volunteers

Filters:

Empagliflozin in Cardiorenal Syndrome Type 1

Tundra lists 1 Empagliflozin in Cardiorenal Syndrome Type 1 clinical trial. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.

This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.

RECRUITING

NCT06030843

The Treatment Effects of Empagliflozin on Renal Outcomes in Cardiorenal Syndrome Type 1

Effects of Empagliflozin compared with placebo in cardiorenal syndrome type 1, evaluated by MAKE30.

Gender: All

Ages: 18 Years - Any

Updated: 2025-08-07

1 state

Empagliflozin in Cardiorenal Syndrome Type 1